185 related articles for article (PubMed ID: 21421525)
1. Morphea as a consequence of accelerated partial breast irradiation.
Wernicke AG; Goltser Y; Trichter S; Sabbas A; Gaan J; Swistel AJ; Magro CM
Clin Breast Cancer; 2011 Mar; 11(1):67-70. PubMed ID: 21421525
[TBL] [Abstract][Full Text] [Related]
2. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
3. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
[TBL] [Abstract][Full Text] [Related]
4. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma.
Chen PY; Vicini FA; Benitez P; Kestin LL; Wallace M; Mitchell C; Pettinga J; Martinez AA
Cancer; 2006 Mar; 106(5):991-9. PubMed ID: 16421922
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
[TBL] [Abstract][Full Text] [Related]
6. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
7. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
[TBL] [Abstract][Full Text] [Related]
8. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
[TBL] [Abstract][Full Text] [Related]
9. Objective and longitudinal assessment of dermatitis after postoperative accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy in patients with breast cancer treated with breast conserving therapy: reduction of moisture deterioration by APBI.
Tanaka E; Yamazaki H; Yoshida K; Takenaka T; Masuda N; Kotsuma T; Yoshioka Y; Inoue T
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1098-104. PubMed ID: 20932653
[TBL] [Abstract][Full Text] [Related]
10. Three-year clinical outcome using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation (APBI): improving radiation standards for the optimal application of APBI.
Israel PZ; Robbins A; Shroff P; Brown S; McLaughlin M; Pope K
Brachytherapy; 2012; 11(4):316-21. PubMed ID: 21925955
[TBL] [Abstract][Full Text] [Related]
11. A case report on bilateral partial breast irradiation using SAVI.
Gloi AM; Buchanan R; Nuskind J; Zuge C; Goettler A
Med Dosim; 2012; 37(2):214-20. PubMed ID: 22192486
[TBL] [Abstract][Full Text] [Related]
12. Late chest wall toxicity after MammoSite breast brachytherapy.
Brashears JH; Dragun AE; Jenrette JM
Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
[TBL] [Abstract][Full Text] [Related]
13. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology.
Stull TS; Catherine Goodwin M; Gracely EJ; Chernick MR; Carella RJ; Frazier TG; Barrio AV
Ann Surg Oncol; 2012 Feb; 19(2):553-9. PubMed ID: 21769461
[TBL] [Abstract][Full Text] [Related]
14. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
[TBL] [Abstract][Full Text] [Related]
15. Morphea of the breast. Two case reports and discussion of the literature.
Dancey AL; Waters RA
J Plast Reconstr Aesthet Surg; 2006; 59(10):1114-7. PubMed ID: 16996439
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric feasibility and acute toxicity in a prospective trial of ultrashort-course accelerated partial breast irradiation (APBI) using a multi-lumen balloon brachytherapy device.
Khan AJ; Vicini FA; Brown S; Haffty BG; Kearney T; Dale R; Lyden M; Arthur D
Ann Surg Oncol; 2013 Apr; 20(4):1295-301. PubMed ID: 23149853
[TBL] [Abstract][Full Text] [Related]
17. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
[TBL] [Abstract][Full Text] [Related]
18. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer.
Suh WW; Pierce LJ; Vicini FA; Hayman JA
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):790-6. PubMed ID: 15936561
[TBL] [Abstract][Full Text] [Related]
19. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
Vicini F; Beitsch PD; Quiet CA; Keleher AJ; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer HM; Lyden M
Cancer; 2008 Feb; 112(4):758-66. PubMed ID: 18181095
[TBL] [Abstract][Full Text] [Related]
20. Angiosarcoma following MammoSite partial breast irradiation.
Andrews S; Wilcoxon R; Benda J; Jacobson G
Breast Cancer Res Treat; 2010 Nov; 124(1):279-82. PubMed ID: 20496164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
